|
1
|
Pingree TF, Kim DR, Owen R and Larry D:
Treatment of hypopharyngeal carcinoma: A 10-year review of 1,362
cases. Laryngoscope. 97:901–904. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Newman JR, Connolly TM, Illing EA, Kilgore
ML, Locher JL and Carroll WR: Survival trends in hypopharyngeal
cancer: A population-based review. Laryngoscope. 125:624–629. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu PY and Chang SY: Reconstruction of the
hypopharynx after surgical treatment of squamous cell carcinoma. J
Chin Med Assoc. 72:351–355. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koga Y, Pelizzola M, Cheng E, Krauthammer
M, Sznol M, Ariyan S, Narayan D, Molinaro AM, Halaban R and
Weissman SM: Genome-wide screen of promoter methylation identifies
novel markers in melanoma. Genome Res. 19:1462–1470. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mori K, Enokida H, Kagara I, Kawakami K,
Chiyomaru T, Tatarano S, Kawahara K, Nishiyama K, Seki N and
Nakagawa M: CpG hypermethylation of collagen type I alpha 2
contributes to proliferation and migration activity of human
bladder cancer. Int J Oncol. 34:1593–1602. 2009.PubMed/NCBI
|
|
6
|
Shin K, Lim A, Zhao C, Sahoo D, Pan Y,
Spiekerkoetter E, Liao JC and Beachy PA: Hedgehog signaling
restrains bladder cancer progression by eliciting stromal
production of urothelial differentiation factors. Cancer Cell.
26:521–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shin K, Lee J, Guo N, Kim J, Lim A, Qu L,
Mysorekar IU and Beachy PA: Hedgehog/Wnt feedback supports
regenerative proliferation of epithelial stem cells in bladder.
Nature. 472:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao F, Li M, Xiang R, Zhou X, Zhu L and
Zhai Y: Expression of CLDN6 in tissues of gastric cancer patients:
Association with clinical pathology and prognosis. Oncol Lett.
17:4621–4625. 2019.PubMed/NCBI
|
|
9
|
Zhai JM, An YH, Wang W, Fan YG and Yao GL:
IL-32 expression indicates unfavorable prognosis in patients with
colon cancer. Oncol Lett. 17:4655–4660. 2019.PubMed/NCBI
|
|
10
|
Zhu YZ, Zhou K, Ruan LL, Sun F, Wang G and
Li WF: Metadherin overexpression in perihilar cholangiocarcinoma is
associated with lymph node metastasis and poor prognosis. Oncol
Lett. 17:4514–4520. 2019.PubMed/NCBI
|
|
11
|
Zou X, Feng B, Dong T, Yan G, Tan B, Shen
H, Huang A, Zhang X, Zhang M, Yang P, et al: Up-regulation of type
I collagen during tumorigenesis of colorectal cancer revealed by
quantitative proteomic analysis. J Proteomics. 94:473–485. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang Y, Diehn M, Bollen AW, Israel MA and
Gupta N: Type I collagen is overexpressed in medulloblastoma as a
component of tumor microenvironment. J Neurooncol. 86:133–141.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Misawa K, Kanazawa T, Misawa Y, Imai A,
Endo S, Hakamada K and Mineta H: Hypermethylation of collagen α2
(I) gene (COL1A2) is an independent predictor of survival in head
and neck cancer. Cancer Biomark. 10:135–144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Comprehensive Cancer Network
(NCCN) clinical practice guidelines in oncology, . Head and Neck
Cancer. Version 1. 2019.
|
|
15
|
Kononen J, Bubendorf L, Kallioniemi A,
Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G
and Kallioniemi OP: Tissue microarrays for high-throughput
molecular profiling of tumor specimens. Nat Med. 4:844–847. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen J, Li S, Xiao Y, Zou X, Zhang X, Zhu
M, Cai M and Xie D: p53R2 as a novel prognostic biomarker in
nasopharyngeal carcinoma. BMC Cancer. 17:8462017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carvalho AL, Nishimoto IN, Califano JA and
Kowalski LP: Trends in incidence and prognosis for head and neck
cancer in the United States: A site-specific analysis of the SEER
database. Int J Cancer. 114:806–816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koo BS, Lim YC, Lee JS, Kim YH, Kim SH and
Choi EC: Management of contralateral N0 neck in pyriform sinus
carcinoma. Laryngoscope. 116:1268–1272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kuo P, Chen MM, Decker RH, Yarbrough WG
and Judson BL: Hypopharyngeal cancer incidence, treatment, and
survival: Temporal trends in the United States. Laryngoscope.
124:2064–2069. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YL, Feng SH, Zhu J, Zhu J, Zhu GP, Li
DS, Wang Y, Zhu YX, Sun GH and Ji QH: Impact of lymph node ratio on
the survival of patients with hypopharyngeal squamous cell
carcinoma: A population-based analysis. PLoS One. 8:e566132013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abrahão R, Anantharaman D, Gaborieau V,
Abedi-Ardekani B, Lagiou P, Lagiou A, Ahrens W, Holcatova I, Betka
J, Merletti F, et al: The influence of smoking, age and stage at
diagnosis on the survival after larynx, hypopharynx and oral cavity
cancers in Europe: The ARCAGE study. Int J Cancer. 143:32–44. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang J, Hsueh CY, Cao W and Zhou L:
Pretreatment lymphocyte-to-monocyte ratio as an independent
prognostic factor for hypopharyngeal squamous cell carcinoma. Acta
Otolaryngol. 138:734–740. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kuwahara T, Takahashi H, Sano D, Matsuoka
M, Hyakusoku H, Hatano T, Hiiragi Y and Oridate N: Fibrinogen and
neutrophil-to-lymphocyte ratio predicts survival in patients with
advanced hypopharyngeal squamous cell carcinoma. Anticancer Res.
38:5321–5330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Liu Y, Ni H, Ding C, Zhang X and
Zhang Z: FoxM1 overexpression promotes cell proliferation and
migration and inhibits apoptosis in hypopharyngeal squamous cell
carcinoma resulting in poor clinical prognosis. Int J Oncol.
51:1045–1054. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu H, Chen J, Wang Q, Yin Y, Da P, Le H,
Zhang Z and Qiu X: Abnormal expression of HAX-1 is associated with
cellular proliferation and migration in human hypopharyngeal
squamous cell carcinoma. Mol Med Rep. 16:4664–4670. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu P, Weaver VM and Werb Z: The
extracellular matrix: A dynamic niche in cancer progression. J Cell
Biol. 196:395–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Egeblad M, Rasch MG and Weaver VM: Dynamic
interplay between the collagen scaffold and tumor evolution. Curr
Opin Cell Biol. 22:697–706. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bonazzi VF, Nancarrow DJ, Stark MS, Moser
RJ, Boyle GM, Aoude LG, Schmidt C and Hayward NK: Cross-platform
array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as
genes frequently silenced by methylation in melanoma. PLoS One.
6:e261212011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhuo C, Li X, Zhuang H, Tian S, Cui H,
Jiang R, Liu C, Tao R and Lin X: Elevated THBS2, COL1A2, and SPP1
expression levels as predictors of gastric cancer prognosis. Cell
Physiol Biochem. 40:1316–1324. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rong L, Huang W, Tian S, Chi X, Zhao P and
Liu F: COL1A2 is a novel biomarker to improve clinical prediction
in human gastric cancer: Integrating bioinformatics and
meta-analysis. Pathol Oncol Res. 24:129–134. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin J, Goldstein L, Nesbit A and Chen MY:
Influence of hormone receptor status on spinal metastatic lesions
in patients with breast cancer. World Neurosurg. 85:42–48. 2016.
View Article : Google Scholar : PubMed/NCBI
|
